Relationship between nonalcoholic fatty liver disease and liver fibrosis risk scales with overweight and obesity scales in 219,477 spanish workers

[eng] Introduction: Non-alcoholic fatty liver disease (NAFLD) is a highly prevalent pathology of multifactorial etiology that can lead to liver fibrosis. The aim of this study is to assess the association between NASFLD and liver fibrosis risk scales and overweight-obesity scales....

Descripción completa

Detalles Bibliográficos
Autores: Martínez-Almoyna Rifá, Emilio, Tomás-Gil, Pilar, Coll Villalonga, Josep Lluis, Ramírez-Manent, José Ignacio, Martí-Lliteras, Pau, López-Gónzalez, Ángel Arturo
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2023
País:España
Institución:Universidad de las Islas Baleares
Repositorio:Biblioteca Digital de les Illes Balears
OAI Identifier:medicinaBalear:AJHS_Medicina_Balear_2023v38n4p092
Acceso en línea:http://ibdigital.uib.es/greenstone/sites/oai-site/collect/medicinaBalear/index/assoc/AJHS_Med/icina_Ba/lear_202/3v38n4p0/92.dir/AJHS_Medicina_Balear_2023v38n4p092.pdf
http://ibdigital.uib.es/greenstone/library/collection/medicinaBalear/document/AJHS_Medicina_Balear_2023v38n4p092
Access Level:acceso abierto
Palabra clave:Liver -- Diseases
Health Sciences
Descripción
Sumario:[eng] Introduction: Non-alcoholic fatty liver disease (NAFLD) is a highly prevalent pathology of multifactorial etiology that can lead to liver fibrosis. The aim of this study is to assess the association between NASFLD and liver fibrosis risk scales and overweight-obesity scales. Material and methods: Descriptive and cross-sectional study in 219477 Spanish workers in which the relationship between the values of different NASH risk scales such as Fatty liver index (FLI), Hepatic steatosis index (HSI), Zhejiang University index (ZJU), Fatty liver disease index (FLD), Framingham steatosis index (Framingham steatosis index), Zhejiang University index (ZJU) and Fatty liver disease index (FLD) was determined, Framingham steatosis index (FSI), Lipid accumulation Product (LAP) and liver fibrosis (BARD score) with values of overweight-obesity scales (waist/height index, body mass index, Clínica Universitaria de Navarra Body Fat Estimator (CUN BAE) and Metabolic Score for Visceral Fat (METS-VF). Results: Both the mean values and the prevalence of high-risk values for NASH and liver fibrosis are higher in people with obesity determined with all the scales. The highest prevalences are obtained when applying the BMI and CUN BAE scales. Conclusion: The close relationship between the values of different NASH and liver fibrosis risk scales and the values of overweightobesity scales is confirmed.